Area of research
Cardiology and Cardiovascular Medicine · Economics and Econometrics
Research interest
Dr. Krumholz has been honored by membership in the National Academy of Medicine, the Association of American Physicians, and the American Society for Clinical Investigation. He was named a Distinguished Scientist of the American Heart Association and received their Award of Meritorious Achievement and Clinical Research Prize. He served as a member of the Advisory Committee to the Director of the National Institutes of Health. Dr. Krumholz received the Friendship Award from the People’s Republic of China in recognition of his collaborative efforts to develop a national cardiovascular research network and was named by the Chinese Society of Cardiology as a Top-10 Distinguished International Cardiologist for his contributions to the development of cardiovascular medicine in China. He founded the American Heart Association’s Quality of Care and Outcomes Research Council and co-founded their annual conference. He was the founding editor of Circulation: Cardiovascular Quality and Outcomes; founding editor of CardioExchange, a social media site of the publisher of the New England Journal of Medicine; and editor of Journal Watch Cardiology of the New England Journal of Medicine. He was a founding Governor of the Patient-Centered Outcomes Research Institute. He is the Editor-in-Chief of JACC, a pre-eminent cardiovascular medical journal.
Principles to guide clinical AI readiness and move from benchmarks to real-world evaluation
Antiphospholipid antibodies and cardiovascular thrombosis
Artificial intelligence-based automated interpretation of images of electrocardiograms: development and multinational validation of ECG-GPT
Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes
Assessing the Secondary Use and Scientific Impact of Shared Clinical Trial Data: A Cross-Sectional Study of Clinical Trials Shared on the YODA Project Platform
Primary Prevention Antihypertensive Eligibility With the 2025 AHA/ACC Guideline
Exploratory analyses of Immunologic Features in a Randomized, Placebo-Controlled Trial of Nirmatrelvir/Ritonavir for Long COVID
Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence–Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials
Sex differences in all-cause and cause-specific mortality and years of life lost in the United States, 2000-2023
Spatial and racial/ethnic disparities in cardiovascular mortality attributable to PM
<sub>2.5</sub>
components in the contiguous United States
Missed Opportunities for Stroke Prevention in Hypertensive Patients: A Retrospective Case-Control Study
Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study
Targeting the SARS-CoV-2 reservoir in long COVID
Artificial Intelligence–Enhanced Risk Stratification of Cancer Therapeutics–Related Cardiac Dysfunction Using Electrocardiographic Images
Artificial Intelligence–Enabled Prediction of Heart Failure Risk From Single-Lead Electrocardiograms
Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial
Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination
Artificial intelligence-enabled electrocardiography and echocardiography to track preclinical progression of transthyretin amyloid cardiomyopathy
Development and multinational validation of an ensemble deep learning algorithm for detecting and predicting structural heart disease using noisy single-lead electrocardiograms
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID
Development and multinational validation of an ensemble deep learning algorithm for detecting and predicting structural heart disease using noisy single-lead electrocardiograms
Identification of hypertrophic cardiomyopathy on electrocardiographic images with deep learning
Floods and cause-specific mortality in the United States applying a triply robust approach
Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria
Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide
Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort
Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID
Internal Tremors and Vibrations in Long COVID: A Cross-Sectional Study
Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States